OpenLegislation

Regulation 5 Amendment of the Health Service Medicines (Control of Prices of Branded Medicines) Regulations 2000

Original text. Later amendments are not shown.

In the Health Service Medicines (Control of Prices of Branded Medicines) Regulations 2000f1, in regulation 2 (interpretation), in paragraph (1), in paragraph (b) of the definition of “marketing authorisation”, for “by the European Agency for the Evaluation of Medicinal Products” substitute “by the European Commission”.

Annotations

Footnotes

f1

S.I 2000/123; as amended by S.I. 2002/236.